Early evaluation of risk stratification and clinical outcomes for patients with advanced breast cancer through combined monitoring of baseline circulating tumor cells and DNA.

Qiang Zhang Zheng Cai Lorenzo Gerratana Andrew A Davis Paolo D'Amico Akhil Chawla Saya L Jacob Youbin Zhang Jianhua Jiao Weijun Qin Giancarlo Feliciello Lisa Flaum Ami N Shah William J Gradishar

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

Assessing the baseline levels of CTCs, CTC-clusters, and mutational ctDNA profile could reliably aid in differentiation of clinical stage and early prediction of metastasis and outcomes in advanced BCa.

Keyphrases

circulating tumor cells
circulating tumor
cell free
type diabetes
single molecule
metabolic syndrome
young adults